20:34 13 October 2026
Proacta has contract with Ares Thera to provide support services in AI and data analysis
Proacta has signed a framework agreement with Ares Thera to provide technology services supporting the development of Ares Thera’s products. The work will focus on artificial intelligence, medical data analysis, and selected validation and regulatory compliance needs. Proacta says demand is growing for projects that combine AI model development with reliable data, validation and regulatory requirements, and that healthcare and MedTech services are part of its growth strategy.
Ares Thera is developing a noninvasive microwave-based system for cancer diagnosis and ablation, combining radio technologies with AI. Proacta is a bioinformatics company listed on Poland’s NewConnect market. The announcement did not disclose the contract’s financial value or duration.
